1. PI - Phase III A Study the Venous Thromboembolic Risk 2016-2018
2. SC - Phase III Diabetes Mellitus type 2 (2014-2016 current)
3. SI - Phase III COPD treatment study (2014-2015)
4. SI - Phase III pneumonia treatment study, (2014-2015)
5. Phase of the study III, Cardiological Study, Sub investigator (2014-2015)
6. Phase of the study III, Nephrology, Sub investigator (2014-2015)
7. Phase of the study III COPD and Cardiovascular Diseases;
8. Phase of the study III for type 2 Diabetes and Cardiovascular Diseases
9. Phase of the study III, for type 2 Diabetes and Cardiovascular Diseases,
10. Phase III, 1 study in Cardiovascular Diseases
11. Phase III Ponesimod in adult with relapsing multiple sclerosis
12. Phase of the study II, Indication Rheumatology, /2016 – 2018/
13. Phase of the study III, Indication Nephrology, /2017 – 2018/
14. Phase of the study III, Indication Cardiology, /2014 – 2015/
15. Phase of the study III, Indication Nephrology, /2017 – 2018/
16. Phase of the study III, Global Alliance for TB Drug Development 11/2017-12/2021
17. Phase of the study III, International Science and Technology Center (ISTC) 2016-2018,
18. Phase of the study III, randomized controlled multi-center trial, 01/2020-01/2025
19. Phase IV, New Diagnostics, TB- Disease, 2015-2017,
20. Phase IV, Tuberculosis, National Institute of Allergy and Infectious Diseases, 2015-2017
21. Phase of the study III-IV, in tuberculosis. 2013-2018
22. Phase of the study III Human Diagnostic, IC in TB Hospital, 2015 – 2016,
23. Swiss National Fund, Switzerland Georgia, 2009-2012, Disability Status Assessment project
24. Timeline 2014-2015, Phase of the study III, Indication Cardiology, Role Subinvestigator
25. Timeline 2017-2018, Phase of the study III, Indication Nephrology, Role Subinvestigator
26. Timeline 2016-2018, Phase of the study II, Indication Rheumatology, Role Subinvestigator
27. Timeline 2010 – 2013, Phase of the study III, Indication Cardiology, Role Subinvestigator
28. Timeline 2020 -present, Phase of the study II, Indication Rheumatology, Role Subinvestigator
29. Timeline 2019 -present, Phase of the study III, Indication Cardiology, Role Pharmacist
30. Timeline 2017-2018, Phase of the study III, Indication Nephrology, Role Pharmacist
31. Timeline 2014 – 2015, Phase of the study III, Indication Cardiology, Role Pharmacist
32. Timeline 2011-12, Phase of the study III, Indication GOUT, Role Subinvestigator
33. Timeline 2012-2014, Phase of the study II, Indication RA, Role Subinvestigator
34. Timeline 2013-2014, Phase of the study II, Indication RA, Role Subinvestigator
35. Timeline 2014-2015, Phase of the study III, Indication RA, Role Subinvestigator
36. Timeline 2016-2018, Phase of the study II, Indication RA, Role Subinvestigator
37. Timeline 2017-2018, Phase of the study II, Indication RA, Role Subinvestigator